Search Results

You are looking at 81 - 90 of 162 items for :

  • All content x
Clear All
Full access

Kaylene Ready and Banu Arun

hyperplasia [ADH], atypical lobular hyperplasia [ALH], lobular carcinoma in situ [LCIS]), age at menarche, parity, breast feeding, diethylstilbestrol (DES) exposure, early breast radiation, hormone replacement therapy, obesity, alcohol intake, family history

Full access

Crystal S. Denlinger, Robert W. Carlson, Madhuri Are, K. Scott Baker, Elizabeth Davis, Stephen B. Edge, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Elizabeth Kvale, Terry S. Langbaum, Jennifer A. Ligibel, Mary S. McCabe, Kevin T. McVary, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Tracey O’Connor, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian, and Deborah Freedman-Cass

(especially hormone therapy, narcotics, and serotonin reuptake receptor inhibitors) that could be a contributing factor. Traditional risk factors for sexual dysfunction, such as cardiovascular disease, diabetes, obesity, smoking, and alcohol abuse, should also

Full access

Nishant Patel, Adam C. Yopp, and Amit G. Singal

other. NAFLD was often associated with components of the metabolic syndrome (obesity, diabetes, dyslipidemia) but was a diagnosis of exclusion, only made in the absence of other causes of liver disease, including viral hepatitis and alcohol abuse

Full access

Chloe E. Atreya, Eric A. Collisson, Meyeon Park, James P. Grenert, Spencer C. Behr, Amalia Gonzalez, Jonathan Chou, Samantha Maisel, Terence W. Friedlander, Chris E. Freise, Jun Shoji, Thomas J. Semrad, Jessica Van Ziffle, and Peter Chin-Hong

transmission at between 0.01% and 0.05% per solid organ transplant. 8 , 9 This risk may be increasing along with donor age and obesity. Meanwhile, there is an ongoing concern for underreporting—and importantly, underdetection—because the etiology of cancer in

Full access

Arjun Gupta, Avash Das, Raseen Tariq, Nizar Bhulani, Naveen Premnath, Dipesh Solanky, Ryan D. Frank, David Johnson, Sahil Khanna, and Muhammad S. Beg

complications, hypertension, liver disease, and obesity were identified using ICD-9-CM diagnosis codes and diagnosis-related group codes. They were assessed using the Charlson comorbidity index. Patients with heart failure and stroke undergoing intubation

Full access

Michael J. Hassett, Wei Jiang, Melissa E. Hughes, Stephen Edge, Sara H. Javid, Joyce C. Niland, Richard Theriault, Yu-Ning Wong, Deborah Schrag, and Rinaa S. Punglia

one-third were age >60 years at diagnosis, 16% were non-white/Hispanic, almost half were overweight/obese (body mass index ≥25 kg/m 2 ), and one-quarter had a comorbidity score ≥1 ( Table 1 ). Infrequently, the initial DCIS was large (≥2 cm in 10%) or

Full access

Kuan-Ling Kuo, David Stenehjem, Frederick Albright, Saurabh Ray, and Diana Brixner

. 3 Other risk factors for HCC include heavy alcohol use, Asian race, male sex with confirmed heritable metabolic diseases (Wilson disease, porphyria cutanea tarda, alpha-1 antitrypsin deficiency, tyrosinemia, and glycogen storage diseases), obesity

Full access

Simon D. Fung-Kee-Fung, Sima P. Porten, Maxwell V. Meng, and Michael Kuettel

with regard to men undergoing RP. Factors that affected overall patient-reported outcomes were large prostate size, obesity, older age, black race, and a high pretreatment PSA. Adjuvant androgen deprivation in the radiation treatment groups exacerbated

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian, and Deborah Freedman-Cass

recommends that treatable contributing factors be assessed and managed. Comorbidities that can contribute to sleep problems include alcohol and substance abuse, obesity, cardiac dysfunction, endocrine dysfunction, anemia, neurologic disorders, pain, fatigue

Full access

Celestia S. Higano

( Table 1 ). 2 ADT has the potential to cause many physical and emotional changes that can diminish longevity (eg, metabolic abnormalities, obesity, sarcopenia, exacerbation of cardiovascular morbidity and mortality, weakened bones resulting in fracture